Body composition in children in remission from acute lymphoblastic leukemia

American Journal of Clinical Nutrition

Volumn 83, Issue 1, 2006, Pages 70-74

  Murphy, Alexia J ^a   Wells, Jonathan C K ^b   Williams, Jane E ^b   Fewtrell, Mary S ^b   Davies, Peter S W ^a   Webb, David K ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

4 component model; Acute lymphoblastic leukemia; Body composition; Dexamethasone; Fat free mass; Prednisolone

Indexed keywords

DEXAMETHASONE; PREDNISOLONE; DEUTERIUM;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; BONE MINERAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDRATION; LEUKEMIA REMISSION; MALE; POPULATION RESEARCH; SURVIVAL; TOTAL BODY WATER; ACUTE LYMPHOCYTIC LEUKEMIA; ADIPOSE TISSUE; BIOLOGICAL MODEL; BODY MASS; BODY WATER; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PLETHYSMOGRAPHY; RADIODENSITOMETRY; REMISSION; SKELETAL MUSCLE;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; BODY WATER; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; DEUTERIUM; DEXAMETHASONE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; PLETHYSMOGRAPHY; PREDNISOLONE; REMISSION INDUCTION;

EID: 33644869061     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.1.70     Document Type: Article

References (43)

1. Mayer EI, Reuter M, Dopfer RE, Ranke MB. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 2000;53:193-9.
2. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 1999;84:4591-6.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21:1359-65.
4. Reilly JJ, Ventham JC, Newell J, Aitchison T, Wallace WH, Gibson BE. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia. Int J Obes Relat Metab Disord 2000;24:1537-41.
5. Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 2000;35:91-5.
6. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 1995;127:63-7.
7. Warner JT, Evans WD, Webb DKH, Gregory JW. Body composition of long-term survivors of acute lymphoblastic leukemia. Med Pediatr Oncol 2002;38:165-72.
8. Must A. Morbidity and mortality associated with elevated body weight in children and adolescents. Am J Clin Nutr 1996;63(suppl):445S-7S.
9. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-20.
10. Wells JCK, Fuller NJ, Dewit O, Fewtrell MS, Elia M, Cole TJ. Four-component model of body composition in children: density and hydration of fat-free mass and comparison with simpler models. Am J Clin Nutr 1999;69:904-12.
11. Haroun D, Wells JCK, Williams JE, Fuller NJ, Fewtrell MS, Lawson MS. Composition of the fat-free mass in obese and nonobese children: matched case-control analyses. Int J Obes (Lond) 2005;29:29-36.
12. Warner JT, Evans WD, Webb DK, Gregory JW. Pitfalls in the assessment of body composition in survivors of acute lymphoblastic leukaemia. Arch Dis Child 2004;89:64-8.
13. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987;5:202-7.
14. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 2003;101:3809-17.
15. Gaynon PS, Carrel AL. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol 1999;457:593-605.
16. Jones B, Freeman AI, Shuster JJ, et al. Lower incidence of meningal leukeamia when prednisolone is replaced by dexamethasone in the treatment of acute lymphocytic leukaemia. Med Pediatr Oncol 1991;19:269-75.
17. Kaspers GJ, Veerman AJ, Popp-Snijders C, et al. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:114-21.
18. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-8.
19. Groot-Loonen JJ, Otten BJ, van't Hof MA, Lippens RJ, Stoelinga GB. Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:92-7.
20. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2003;58:770-6.
21. Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc 1995;27:1692-7.
22. Wells JCK, Fuller NJ. Precision of measurement and body size in whole-body air-displacement plethysmography. Int J Obes Relat Metab Disord 2001;25:1161-7.
23. Wells JC, Fuller NJ, Wright A, Fewtrell MS, Cole TJ. Evaluation of air-displacement plethysmography in children aged 5-7 years using a three-component model of body composition. Br J Nutr 2003;90:699-707.
24. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M. Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Colch) 1992;82:687-93.
25. Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann N Y Acad Sci 1963;110:113-40.
26. Wells JCK, Victora CG. Indices of whole-body and central adiposity for evaluation the metabolic load of obesity. Int J Obes (Lond) (in press).
27. Wells JC. A critique of the expression of paediatric body composition data. Arch Dis Child 2001;85:67-72.
28. Van Itallie TB, Yang M, Heymsfield S, Funk RC, Boileau RA. Height-normalized indices of the body's fat free and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990;52:953-9.
29. Wells JCK, Cole TJ, ALSPAC study team. Adjustment of fat-free mass and fat mass for height in children aged 8 y. Int J Obes Relat Metab Disord 2002;26:947-52.
30. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25-9.
31. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17-24.
32. Odame I, Reilly JJ, Gibson BE, Donaldson MD. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1994;71:147-9.
33. Van Dongen-Melman JE, Hokken-Koelega AC, Hahlen K, De Groot A, Tromp CG, Egeler RM. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995;38:86-90.
34. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM. Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr Suppl 1995;411:45-50.
35. Davies JH, Evans BAJ, Jones E, Evans WD, Jenney MEM, Gregory JW. Osteopenia, excess adiposty and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukemia without cranial irradiation. Clin Endocrinol 2004;60:358-65.
36. Halton JM, Atkinson SA, Barr RD. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia. Int J Cancer Suppl 1998;11:81-4.
37. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-10.
38. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 2001;86:3742-5.
39. Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol 1996;271:E317-25.
40. Reilly JJ, Ventham JC, Ralston JM, Donaldson M, Gibson B. Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia. Pediatr Res 1998;44:557-62.
41. Warner JT, Bell W, Webb DK, Gregory JW. Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res 1998;43:607-13.
42. Màrky L, Mellander L, Lannering B, Albertsson-Wikland K. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1991;19:258-64.
43. Ahmed SF, Tucker P, Mushtaq T, Wallace AM, Williams DM, Hughes IA. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin Endocrinol (Oxf) 2002;57:185-91.